Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

Unless they’re covering me in a cloud of norovirus particles. When the violent expelling of liquid starts somewhere other ...

Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people worldwide every year, and though there is currently no preventive vaccine, a ...

You can also get norovirus by touching objects or surfaces that are contaminated and then putting your hands in your mouth ...

Wisconsin Public Radio If you or someone in your family has been sick with a “stomach bug” lately, you’re not alone.

Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...